These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 11849800

  • 1. ARCON: experience in 215 patients with advanced head-and-neck cancer.
    Kaanders JH, Pop LA, Marres HA, Bruaset I, van den Hoogen FJ, Merkx MA, van der Kogel AJ.
    Int J Radiat Oncol Biol Phys; 2002 Mar 01; 52(3):769-78. PubMed ID: 11849800
    [Abstract] [Full Text] [Related]

  • 2. Accelerated radiotherapy with carbogen and nicotinamide (ARCON) for laryngeal cancer.
    Kaanders JH, Pop LA, Marres HA, Liefers J, van den Hoogen FJ, van Daal WA, van der Kogel AJ.
    Radiother Oncol; 1998 Aug 01; 48(2):115-22. PubMed ID: 9783882
    [Abstract] [Full Text] [Related]

  • 3. ARCON: accelerated radiotherapy with carbogen and nicotinamide in head and neck squamous cell carcinomas. The experience of the Co-operative group of radiotherapy of the european organization for research and treatment of cancer (EORTC).
    Bernier J, Denekamp J, Rojas A, Minatel E, Horiot J, Hamers H, Antognoni P, Dahl O, Richaud P, van Glabbeke M, Piérart M.
    Radiother Oncol; 2000 May 01; 55(2):111-9. PubMed ID: 10799722
    [Abstract] [Full Text] [Related]

  • 4. Accelerated radiotherapy, carbogen and nicotinamide (ARCON) in locally advanced head and neck cancer: a feasibility study.
    Saunders MI, Hoskin PJ, Pigott K, Powell ME, Goodchild K, Dische S, Denekamp J, Stratford MR, Dennis MF, Rojas AM.
    Radiother Oncol; 1997 Nov 01; 45(2):159-66. PubMed ID: 9424007
    [Abstract] [Full Text] [Related]

  • 5. Oxygen-modifying treatment with ARCON reduces the prognostic significance of hemoglobin in squamous cell carcinoma of the head and neck.
    Hoogsteen IJ, Pop LA, Marres HA, Merkx MA, van den Hoogen FJ, van der Kogel AJ, Kaanders JH.
    Int J Radiat Oncol Biol Phys; 2006 Jan 01; 64(1):83-9. PubMed ID: 16213107
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Accelerated radiotherapy, carbogen, and nicotinamide (ARCON) in the treatment of advanced bladder cancer: mature results of a Phase II nonrandomized study.
    Hoskin P, Rojas A, Saunders M.
    Int J Radiat Oncol Biol Phys; 2009 Apr 01; 73(5):1425-31. PubMed ID: 19036531
    [Abstract] [Full Text] [Related]

  • 12. Acute toxicity profile and compliance to accelerated radiotherapy plus carbogen and nicotinamide for clinical stage T2-4 laryngeal cancer: results of a phase III randomized trial.
    Janssens GO, Terhaard CH, Doornaert PA, Bijl HP, van den Ende P, Chin A, Pop LA, Kaanders JH.
    Int J Radiat Oncol Biol Phys; 2012 Feb 01; 82(2):532-8. PubMed ID: 21300447
    [Abstract] [Full Text] [Related]

  • 13. ARCON: a novel biology-based approach in radiotherapy.
    Kaanders JH, Bussink J, van der Kogel AJ.
    Lancet Oncol; 2002 Dec 01; 3(12):728-37. PubMed ID: 12473514
    [Abstract] [Full Text] [Related]

  • 14. Acute effects of accelerated radiotherapy in combination with carbogen breathing and nicotinamide (ARCON).
    Zackrisson B, Franzén L, Henriksson R, Littbrand B, Stratford M, Dennis M, Rojas AM, Denekamp J.
    Acta Oncol; 1994 Dec 01; 33(4):377-81. PubMed ID: 8018369
    [Abstract] [Full Text] [Related]

  • 15. Accelerated radiotherapy, carbogen, and nicotinamide in glioblastoma multiforme: report of European Organization for Research and Treatment of Cancer trial 22933.
    Miralbell R, Mornex F, Greiner R, Bolla M, Storme G, Hulshof M, Bernier J, Denekamp J, Rojas AM, Pierart M, van Glabbeke M, Mirimanoff RO.
    J Clin Oncol; 1999 Oct 01; 17(10):3143-9. PubMed ID: 10506611
    [Abstract] [Full Text] [Related]

  • 16. Pharmacokinetics of nicotinamide in cancer patients treated with accelerated radiotherapy: the experience of the Co-operative Group of Radiotherapy of the European Organization for Research and Treatment of Cancer.
    Bernier J, Stratford MR, Denekamp J, Dennis MF, Bieri S, Hagen F, Kocagöncü O, Bolla M, Rojas A.
    Radiother Oncol; 1998 Aug 01; 48(2):123-33. PubMed ID: 9783883
    [Abstract] [Full Text] [Related]

  • 17. Chemoradiation for advanced head and neck cancer: potential for improving results to match those of current treatment modalities for early-stage tumors--long-term results of hyperfractionated chemoradiation with carbogen breathing and anemia correction with erythropoietin.
    Villar A, Martinez JC, de Serdio JL.
    Int J Radiat Oncol Biol Phys; 2008 Apr 01; 70(5):1382-8. PubMed ID: 18037586
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
    Lauve A, Morris M, Schmidt-Ullrich R, Wu Q, Mohan R, Abayomi O, Buck D, Holdford D, Dawson K, Dinardo L, Reiter E.
    Int J Radiat Oncol Biol Phys; 2004 Oct 01; 60(2):374-87. PubMed ID: 15380569
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.